Ajanta Pharma News: Read Latest News & Live Updates on Ajanta Pharma, Photos, Videos at CNBCTV18.com

homeAjanta Pharma News

Ajanta Pharma NEWS

All

market | May 3, 2024 10:25 AM IST
Ajanta Pharma shares surge to a record high on strong Q4, buyback approval
market | May 2, 2024 5:06 PM IST
Ajanta Pharma board approves ₹285 crore share buyback at a 25% premium
market | Apr 26, 2024 3:49 PM IST
Ajanta Pharma board to consider share buyback on May 2; Stock turns positive for 2024
business | Aug 30, 2023 7:43 PM IST
Ajanta Pharma gets USFDA nod for migraine medicine topiramate extended-release capsules
market | Jul 24, 2023 4:48 PM IST
Ajanta Pharma shares give up gains to end little changed ahead of board meet to consider dividend
business | Jun 26, 2023 3:49 PM IST
Ajanta Pharma's Gujarat plant gets zero observations from USFDA, shares see profit booking at higher levels
market | Mar 10, 2023 10:18 AM IST
Ajanta Pharma approves Rs 315 crore share buyback at Rs 1,425 apiece via tender offer
market | Dec 23, 2022 10:26 AM IST
Here are the two domestic mutual funds that bought shares of Ajanta Pharma in Thursday's large deal
business | Dec 22, 2022 10:08 AM IST
Ajanta Pharma shares rise over 2% after large trade deal
photos | Dec 22, 2022 5:28 AM IST
Stocks to Watch: Reliance Industries, Ajanta Pharma, Bandhan Bank, Sula Vineyards and more
business | Dec 21, 2022 9:02 PM IST
Ajanta Pharma promoters may sell 4.56% stake via block deal on Thursday
market | Dec 1, 2022 4:12 PM IST
Timken India gains after three days; Voltas rebounding: What kept dealers busy on Thursday?
market | Nov 4, 2022 11:21 AM IST
Ajanta Pharma shares drop after profit, margin decline in the September quarter
market | Sept 12, 2022 5:30 PM IST
Auro Pharma ends positive as Street awaits US drug regulator action; Ajanta Pharma in the red
market | Mar 17, 2022 5:58 PM IST
Taking Stock: Market expert Jai Bala positive on Ajanta Pharma and ABFRL

Ajanta Pharma NEWS

Ajanta Pharma shares surge to a record high on strong Q4, buyback approval

Ajanta Pharma board approves ₹285 crore share buyback at a 25% premium

Ajanta Pharma board to consider share buyback on May 2; Stock turns positive for 2024

Ajanta Pharma gets USFDA nod for migraine medicine topiramate extended-release capsules

Ajanta Pharma shares give up gains to end little changed ahead of board meet to consider dividend

Ajanta Pharma's Gujarat plant gets zero observations from USFDA, shares see profit booking at higher levels

Ajanta Pharma approves Rs 315 crore share buyback at Rs 1,425 apiece via tender offer

Here are the two domestic mutual funds that bought shares of Ajanta Pharma in Thursday's large deal

Ajanta Pharma shares rise over 2% after large trade deal

Stocks to Watch: Reliance Industries, Ajanta Pharma, Bandhan Bank, Sula Vineyards and more

Ajanta Pharma promoters may sell 4.56% stake via block deal on Thursday

Timken India gains after three days; Voltas rebounding: What kept dealers busy on Thursday?

Ajanta Pharma shares drop after profit, margin decline in the September quarter

Auro Pharma ends positive as Street awaits US drug regulator action; Ajanta Pharma in the red

Taking Stock: Market expert Jai Bala positive on Ajanta Pharma and ABFRL